Back to Search
Start Over
Novel and multiple targets for chimeric antigen receptor-based therapies in lymphoma.
- Source :
-
Frontiers in oncology [Front Oncol] 2024 Apr 22; Vol. 14, pp. 1396395. Date of Electronic Publication: 2024 Apr 22 (Print Publication: 2024). - Publication Year :
- 2024
-
Abstract
- Chimeric antigen receptor (CAR) T-cell therapy targeting CD19 in B-cell non-Hodgkin lymphoma (NHL) validates the utility of CAR-based therapy for lymphomatous malignancies. Despite the success, treatment failure due to CD19 antigen loss, mutation, or down-regulation remains the main obstacle to cure. On-target, off-tumor effect of CD19-CAR T leads to side effects such as prolonged B-cell aplasia, limiting the application of therapy in indolent diseases such as chronic lymphocytic leukemia (CLL). Alternative CAR targets and multi-specific CAR are potential solutions to improving cellular therapy outcomes in B-NHL. For Hodgkin lymphoma and T-cell lymphoma, several cell surface antigens have been studied as CAR targets, some of which already showed promising results in clinical trials. Some antigens are expressed by different lymphomas and could be used for designing tumor-agnostic CAR. Here, we reviewed the antigens that have been studied for novel CAR-based therapies, as well as CARs designed to target two or more antigens in the treatment of lymphoma.<br />Competing Interests: NG has received research funding from Genentech, Pharmacyclics, Bristol Myers Squibb, AbbVie, Morphosys, Gilead/Kite Pharma; served as a consultant/advisor for AbbVie, AstraZeneca, Genentech, Beigene, Janssen, Lilly, Gilead/Kite Pharma, ADC Therapeutics, Novartis, Lava Therapeutics, Incyte. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2024 Pang and Ghosh.)
Details
- Language :
- English
- ISSN :
- 2234-943X
- Volume :
- 14
- Database :
- MEDLINE
- Journal :
- Frontiers in oncology
- Publication Type :
- Academic Journal
- Accession number :
- 38711850
- Full Text :
- https://doi.org/10.3389/fonc.2024.1396395